We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Hologic

Designs and provides products for clinical laboratory and blood screening, including testing items for detection of h... read more Featured Products: More products

Download Mobile App




Hologic Showcases Extensive Portfolio of Breast and Skeletal Health Products at RSNA 2021

By MedImaging International staff writers
Posted on 01 Dec 2021
Print article
Image: Hologic at RSNA 2021 (Photo courtesy of Hologic, Inc.)
Image: Hologic at RSNA 2021 (Photo courtesy of Hologic, Inc.)

Hologic, Inc. (Marlborough, MA, USA) showcased its extensive portfolio of breast and skeletal health products, including screening and diagnostics solutions, breast biopsy, and breast cancer treatment and monitoring solutions, at RSNA 2021.

Hologic offered attendees opportunities to engage with products, including the Dimensions mammography portfolio, Mach ultrasound systems, and a full suite of breast biopsy and surgery solutions. Hologic demonstrated its new high-performance SuperSonic MACH 40 ultrasound system is designed to help increase efficiency and diagnostic accuracy. Inspired by the video gaming industry, the intelligent signal processing with image capture capacity of up to 20,000 frames per second, brings unlimited possibilities into ultrasound imaging.

Hologic also showcased its Brevera breast biopsy system with CorLumina imaging technology. Brevera is the world’s first and only solution to combine vacuum-assisted tissue acquisition, real-time imaging, verification and advanced post-biopsy handling – all in one, integrated system. Hologic demonstrated its Genius AI Detection Technology, its next generation deep-learning based software detects potential cancers in breast tomosynthesis images. Genius AI Detection technology represents the next breakthrough in helping radiologists identify breast cancers. Using deep learning technology, Genius AI Detection is designed to find cancers with improved accuracy as compared to Hologic’s previous generation CAD, with the software fully integrated on the Dimensions system.

Additionally, the company hosted a series of both CME and non-CME accredited medical education symposiums and lunch-and-learn sessions, accessible to attendees on-site and from remote locations.

“We’re excited to provide our attendees hands-on experiences with our category-leading innovations, both in our booth and during our medical sessions, as we explore the future of breast health at RSNA 2021,” said Jennifer Meade, Hologic’s Division President, Breast and Skeletal Health Solutions. “Our commitment to delivering clinically proven solutions across the continuum of care to improve outcomes, reduce costs and increase patient satisfaction remains steadfast, and we're ready to bring that commitment to life through our comprehensive programming at this year’s meeting both in-person and virtually."

Related Links:
Hologic, Inc. 

NMUS & MSK Ultrasound
InVisus Pro
New
MRI System
Ingenia Prodiva 1.5T CS
Mobile Barrier
Tilted Mobile Leaded Barrier
New
Computed Tomography System
Aquilion ONE / INSIGHT Edition

Print article

Channels

Ultrasound

view channel
Image: Artificial intelligence can improve ovarian cancer diagnoses (Photo courtesy of 123RF)

AI-Based Models Outperform Human Experts at Identifying Ovarian Cancer in Ultrasound Images

Ovarian tumors are commonly found, often by chance. In many regions, there is a significant shortage of ultrasound specialists, which has raised concerns about unnecessary medical interventions and delayed... Read more

Nuclear Medicine

view channel
Image: PSMA-PET/CT images of an 85-year-old patient with hormone-sensitive prostate cancer (Photo courtesy of Dr. Adrien Holzgreve)

Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients

Prostate-specific membrane antigen–portron emission tomography (PSMA-PET) imaging has become an essential tool in transforming the way prostate cancer is staged. Using small amounts of radioactive “tracers,”... Read more

General/Advanced Imaging

view channel
Image: Automated methods enable the analysis of PET/CT scans (left) to accurately predict tumor location and size (right) (Photo courtesy of Nature Machine Intelligence, 2024. DOI: 10.1038/s42256-024-00912-9)

Deep Learning Based Algorithms Improve Tumor Detection in PET/CT Scans

Imaging techniques are essential for cancer diagnosis, as accurately determining the location, size, and type of tumors is critical for selecting the appropriate treatment. The key imaging methods include... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.